Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 0.00% is 100% above its 1-year average of -2577.93%, near the high end of its 1-year range (-8917.78%–0.00%).
100.00% above its 12-month average of -2577.93%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -3971.89%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
-2577.93%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+100.00%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Tenaya Therapeutics, Inc.
Market Cap
$120.17M
Operating Margin
0.00%
TTM Avg
-2577.93%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$119.62M
Operating Margin
-477.46%
TTM Avg
-238.73%
3Y Avg
-136.84%
5Y Avg
-91.23%
Market Cap
$120.92M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$118.90M
Operating Margin
0.00%
TTM Avg
-571.68%
3Y Avg
-414.68%
5Y Avg
-276.45%
Market Cap
$121.51M
Operating Margin
-483.85%
TTM Avg
-600.79%
3Y Avg
-640.11%
5Y Avg
-1468.53%
Market Cap
$122.13M
Operating Margin
-1853.92%
TTM Avg
-1829.87%
3Y Avg
-8864.53%
5Y Avg
-5959.13%
Market Cap
$112.28M
Operating Margin
-33.18%
TTM Avg
-17.71%
3Y Avg
-9.45%
5Y Avg
-4.00%
Market Cap
$115.88M
Operating Margin
-255.05%
TTM Avg
-370.20%
3Y Avg
-218.02%
5Y Avg
-145.34%
Market Cap
$124.84M
Operating Margin
-959.05%
TTM Avg
-1156.66%
3Y Avg
-959.32%
5Y Avg
-639.55%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tenaya Therapeutics, Inc. (TNYA) | $120.17M | 0.00% | -2577.93% | 0.00% | 0.00% |
| LENZ Therapeutics, Inc. (LENZ)vs › | $119.62M | -477.46% | -238.73% | -136.84% | -91.23% |
| enGene Holdings Inc. (ENGN)vs › | $120.92M | 0.00% | 0.00% | 0.00% | 0.00% |
| Spruce Biosciences, Inc. (SPRB)vs › | $118.90M | 0.00% | -571.68% | -414.68% | -276.45% |
| Seer, Inc. (SEER)vs › | $121.51M | -483.85% | -600.79% | -640.11% | -1468.53% |
| Cibus, Inc. (CBUS)vs › | $122.13M | -1853.92% | -1829.87% | -8864.53% | -5959.13% |
| BGM Group Ltd. (BGM)vs › | $112.28M | -33.18% | -17.71% | -9.45% | -4.00% |
| Coya Therapeutics, Inc. (COYA)vs › | $115.88M | -255.05% | -370.20% | -218.02% | -145.34% |
| Tonix Pharmaceuticals Holding Corp. (TNXP)vs › | $124.84M | -959.05% | -1156.66% | -959.32% | -639.55% |
| Lucid Diagnostics Inc. (LUCD)vs › | $114.46M | -1054.82% | -1057.23% | -4752.68% | -4082.42% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -3971.89% |
| 2026-03-31 | -8917.78% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
